PARP4 与 hnRNPM 相互作用,以调节肺癌进展期间的拼接
Yi Fei Lee1,2, Cheryl Zi Jin Phua1, Ju Yuan1
1Genome Institute of Singapore (GIS), Agency for Science, Technology and Research (A*STAR), 60 Biopolis Street, Genome, Singapore, 138672, Singapore.
Genome medicine
|July 21, 2024
概括
聚 ((ADP-ribose) 聚合酶4 (PARP4) 通过调节结合,独立于体复合体,在肺腺癌中起到瘤抑制作用. 它与hNRNPM的新奇相互作用突出显示了癌症进展中的拼接失调.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 癌症驱动基因的识别对于理解瘤生物学和开发向治疗非常重要.
- 在癌症发育中较少发生突变的机制需要进一步研究.
- 这项研究侧重于使用最大的亚洲肺腺癌 (LUAD) 队列的新型驱动器PARP4.
研究的目的:
- 功能性地评估PARP4在肺腺癌中的机械作用.
- 研究PARP4的相互作用伙伴及其在瘤发生中的作用.
- 探索PARP4,拼接变化和LUAD发展之间的联系.
主要方法:
- 进行了体外和体内瘤发生性测试,以评估PARP4损失和突变的影响.
- 使用定量质谱的互动组学分析确定了PARP4的相互作用伙伴.
- 来自细胞系和患者瘤的转录组数据被分析,以调查拼接变化.
主要成果:
- PARP4 枯竭或突变 (I1039T) 增强了 KRAS 或 EGFR 驱动的肺癌细胞的瘤性.
- PARP4的瘤抑制活性是独立于密室复合体的.
- 拼接调节器 hnRNPM 被确定为一种新的 PARP4 相互作用伙伴; 它的损失也促进了瘤的形成,并导致拼接扰乱,类似于 PARP4 淘汰和 LUAD 患者的 PARP4 副本数损失.
结论:
- PARP4是一种新型瘤抑制剂,用于肺腺癌.
- PARP4的瘤抑制活性是通过其与 hnRNPM 的相互作用来调节的,而不是金库综合体.
- 受 PARP4 和 hnRNPM 影响的剪接失调在 LUAD 瘤发生中起着重要作用.
相关概念视频
Chromatin Structure Regulates pre-mRNA Processing
7.0K
In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...
The chromatin structure, especially...
7.0K
RNA Splicing
56.3K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.3K
Alternative RNA Splicing
21.1K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.1K
Pre-mRNA Processing: RNA Splicing
5.2K
5.2K
Restarting Stalled Replication Forks
5.8K
DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
5.8K
Nonsense-mediated mRNA Decay
10.6K
The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
10.6K


